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Progression of chronic kidney disease (CKD) is characterized by deposition of extracellular matrix. This is an irreversible process
that leads to tubulointerstitial fibrosis and finally loss of kidney function. Wnt/𝛽-catenin pathway was reported to be aberrantly
activated in the progressive damage associated with chronic organ failure. Extensive renal ablation is an experimental model widely
used to gain insight into the mechanisms responsible for the development of CKD, but it was not evaluated for Wnt/𝛽-catenin
pathway. This study aimed to elucidate if the rat 5/6 renal mass reduction model (RMR) is a good model for the Wnt/𝛽-catenin
activation and possible next modulation. RMRmodel was evaluated at 12 and 18 weeks after the surgery, when CKD is close to end-
stage kidney disease demonstrated by molecular and histological studies. Wnt pathway components were analyzed at mRNA and
protein level. Our results demonstrate that Wnt pathway is active by increase of 𝛽-catenin at mRNA level and nuclear translocation
in tubular epithelium as well as some target genes. These results validate the RMR model for future modulation of Wnt pathway,
starting at shorter time after the surgery.
1. Introduction
Progression of chronic kidney disease (CKD) is characterized
by deposition of extracellular matrix (ECM). This is an
irreversible process that leads to tubulointerstitial fibrosis
and finally loss of kidney function. It is widely accepted
that epithelial-to-mesenchymal transition (EMT) is the main
factor responsible for organ fibrosis. EMT is defined as
phenotypic change of fully differentiated epithelial cells to
matrix-producing fibroblasts [1].
Several studies have suggested that specific signal path-
ways may affect the development of fibrosis in the kidney
and contribute to epithelial cell injury and fibroplasia. Some
of the signaling mediators involved include proinflamma-
tory and profibrotic cytokines produced by infiltrating and
resident cells, such as interferon-𝛾, tumor necrosis factor-𝛼,
interleukin-1-𝛽, and transforming growth factor-𝛽-1 (TGF-𝛽)
[2].
The TGF-𝛽 signaling pathway plays a pivotal role in
embryonic development and organogenesis and is a key
fibrogenic cytokine in several fibrotic diseases of the kidney,
lung, and other organs. Campistol et al. have previously
demonstrated that TGF-𝛽 serum levels were significantly
higher in kidney transplant patients with interstitial fibrosis
and tubular atrophy than in those with normal renal function
[3, 4].
TGF-𝛽 has been shown to be critical for extracellular
matrix turnover and for cellular plasticity, such as epithelial-
to-mesenchymal transition. This transition represents the
phenotypic, reversible switching of epithelial to fibroblast-
like cells and may play a major role in the pathogenesis of
CKD, increasing the number of activated fibroblasts derived
from epithelial cells [5–7]. The role of TGF-𝛽 in fibrogenic
processes and renal fibrosis has been widely described, as has
been the role of crosstalk between TGF-𝛽 andWnt/𝛽-catenin
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pathways in cell fate determination during embryonic devel-
opment and in the adult [8]. Crosstalk between two pathways
could be carried out by transregulation, whereby one pathway
regulates specific components of the other or through cross-
communication between components of the pathways. For
example, the stability of the intracellular signal transducers of
theTGF-𝛽pathway, the SMADproteins, can also be regulated
by axin, a regulator of Wnt signaling. However, there is little
evidence of interdependence or retroregulation between the
components of the two pathways in transcriptional regulation
of target genes in mammals, particularly in the context of
epithelial-to-mesenchymal transition and organ fibrosis [8].
Over the last years, the Wnt/𝛽-catenin pathway was
reported to be aberrantly activated in the progressive damage
associatedwith chronic organ failure [9, 10].Wnts are a family
of 19 proteins essential for organ development, a process
that has been described to be recapitulated in organ failure.
Canonical Wnt pathway involves the cytoplasmic protein 𝛽-
catenin. In the absence of Frizzled (FZD) receptor binding
of Wnt ligands, 𝛽-catenin is constitutively phosphorylated
by glycogen sintase kinase-3𝛽 (GSK-3𝛽) and subsequently
degrades by the complex composed of the adenomatous
polyposis coli protein (APC) and axin. In the presence of
Wnt ligand binding to a FZD receptor and a low density
receptor (LRP) coreceptor leads to the phosphorylation of
disheveled protein in the cytoplasm (DVL). The activated
DVL binds to axin in order to antagonize the action of GSK-
3𝛽; subsequently 𝛽-catenin phosphorylation and ubiquitina-
tion are inhibited. This causes a citoplasmatic accumulation
of𝛽-catenin in the cytoplasmand translocation to the nucleus
where it regulates target gene expression through interaction
with members of the TCF/LEF family of HGM-domain
transcription factors [9, 10].
Increased Wnt/𝛽-catenin signaling has been shown to
be involved in epithelial cell injury and hyperplasia, as well
as in impaired epithelial-mesenchymal crosstalk in fibrosis.
Modulation of Wnt signaling led to an attenuation of lung
fibrosis in vivo [9], while altered expression of Wnt signaling
components has been reported in several renal diseases [11]
and animal models, such as rat chronic allograft dysfunction
model [2], unilateral ureteral obstruction model [12], lupus
nephritis [13], or diabetic nephropathy [14].
Several CKD animal models have been used to study the
mechanisms responsible for the disease progression. Exten-
sive renal ablation is an experimental model widely used to
gain insight into the mechanisms responsible for the devel-
opment of CKD since it causes a combination of glomerular
hemodynamic alterations and nonhemodynamic events that
result in progressive glomerulosclerosis, tubulointerstitial
damage, proteinuria, and renal functional impairment in the
remnant kidney. There is early glomerulosclerosis by week
4, with segmental sclerosis with tubulointerstitial fibrosis by
week 8 [15, 16].
This study aimed to elucidate if the 5/6 renal mass
reduction model is a good model for the Wnt/𝛽-catenin
activation and possible next modulation. To do this, we used
5/6 renal mass reduction model animals and we sacrificed
animals at 12 and 18 weeks after the surgery, when CKD
is well established, and then we characterized the fibrosis
establishment and the Wnt activation.
2. Methods
2.1. Antibodies and Reagents. In this study, the following anti-
bodies were used: total 𝛽-catenin (number 9562), phospho-
S9- and totalGSK-3𝛽 (numbers 9336 and 9315), phospho- and
total LRP6 (numbers 2568 and 2560), and phospho-SMAD3
(C25A9) (all from Cell Signaling Technology, Beverly, MA);
Wnt1 (600-401-A37) (Rockland, Gilbertsville, PA); 𝛼-SMA
(A2547); Ca2+ATPase (A7952); cyclin D1 (C7464); GADPH
(G9545); 𝛽-actin (A3854); Pan CK (F3418); Desmin (D1033)
and SIS3 (S0447) (all from Sigma-Aldrich, Saint Louis, MO);
FBPase (sc-166097) and factor VIII (sc-27647) (from Santa
Cruz Biotechnology, Santa Cruz, CA); Alexa Fluor 568
phalloidin (A-12380) (Invitrogen); vimentin (AB1620) and
TGF-𝛽 (MAB1032) (fromMillipore, Billerica, MA).
2.2. Animal Model: The 5/6 Renal Mass Reduction
2.2.1. Animals. Male Wistar rats (Charles River Laboratories
España, Barcelona, Spain)weighing approximately 225 gwere
used. The rats were kept at a constant temperature and
humidity and at a 12 h light/dark cycle. The animals had free
access to standard rat chow (Harlan Interfauna Iberica, S.L.,
Barcelona, Spain) and water.
This study was approved by and conducted according
to the guidelines of the Local Animal Ethics Commit-
tee (Comitè Ètic d’Experimentació Animal, CEEA, Decret
214/97, Catalunya, Spain).
2.2.2. Experimental Design. Animals (𝑛 = 33) were ran-
domly assigned to two groups according to the surgical
intervention. One group was assigned to undergo renal mass
reduction (nephrectomized group (Nx)) and the other to
have a sham operation (sham group (S)). Surgical procedures
were performed under general anesthesia with isoflurane
(Forane; Abbott Laboratories, S.A., Madrid, Spain). After
an abdominal incision, the left kidney was exposed and
separated from the adrenal gland. The lower and upper poles
of the left kidney were frozen by application of a cylinder of
dry ice of standard size for 2 minutes on each pole. After one
week, the right kidney was removed. The sham group rats
underwent the same abdominal incision and manipulation
of the left and the right kidneys without tissue destruction
as described by Rovira et al. [15, 16].
2.3. Renal Function Parameters. Serum creatinine, BUN, pro-
teinuria, urinary creatinine, and proteinuria/creatinine ratios
were determined 1-2 days before sacrifice. To collect urine
samples the rats were housed in metabolic cages separately
for 24 h.
2.4. Tissue Collection. At the end of the study, the rats were
killed and kidney samples were harvested. Central slide from
kidney was fixed in formalin and embedded in paraffin by
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Table 1: Biochemical parameters for renal function evaluation.
Diuresis Proteinuria Urinary creatinine Creatinine BUN Creatinine
(mL) (mg/24 h) (mg/24 h) (mg/dL) (mg/dL) clearance
12 weeks Sham 18.13 ± 8.25 19.88 ± 6.33 18.75 ± 2.25 0.57 ± 0.06 16.88 ± 1.25 2.32 ± 0.37
5/6Nx 34.88 ± 11.13 150.75 ± 65.97 12.75 ± 2.43 1.29 ± 0.31 66.63 ± 18.62 0.73 ± 0.24
18 weeks Sham 15.37 ± 4.00 13.37 ± 4.21 19.5 ± 2.00 0.6 ± 0.06 18.38 ± 2.50 2.21 ± 0.25
5/6Nx 27.85 ± 6.96 143 ± 37.40 10.71 ± 3.95 1.63 ± 0.44 92.28 ± 31.77 0.53 ± 0.36
routine methods. The remaining tissue was snap-frozen and
stored at −80∘ until use.
2.5. Reverse Transcription and Quantitative Real-Time PCR.
Total RNAwas extracted by using a Perfect Pure RNA fibrous
Tissue Kit (5PRIME, Hamburg, Germany) from renal tissue
(human and rat) and by using RNeasy Mini Kit (Qiagen,
Hilden, Germany) extraction kits according to the manufac-
turer’s protocol. cDNAs were generated by reverse transcrip-
tion usingMuLV reverse transcriptase (Roche, Indianapolis).
Quantitative (q)RT-PCR was performed using Light Cycler
480 SyBr Green I master (Roche), as previously described.
r RPL19, ubiquitously and equally expressed gene free of
pseudogenes, was used as a reference gene in all qRT-PCR
reactions. PCR was performed using the primers at a final
concentration of 200 nM. The relative transcript abundance
of a gene is expressed in DCt values (DCt = Ctreference −
Cttarget). Relative changes in transcript levels compared with
controls are expressed in DDCt values (DDCt = DCttreated −
DCtcontrol). All DDCt values correspond approximately to
the binary logarithm of the fold change, as mentioned in
Section 3.
2.6. Protein Extraction from Tissue. Renal rat tissue was
homogenized in extraction buffer QProteome Mammalian
Protein Preparation Kit (QIAGEN), and the whole proteins
were extracted by centrifugation (14,000 rpm) for 10min
at 4∘C, as recommended by the supplier. Proteins were
quantified using theMicro BCA Protein Assay Kit (PIERCE).
2.7. Western Blot. Samples containing 30 𝜇g of protein were
separated by electrophoresis on SDS polyacrylamide gels.
The separated proteins were transferred to PVDF mem-
branes (BioRad), blocked with 5% skimmed milk or BSA
depending on customer indication, and incubated with the
indicated antibodies. The proteins were then visualized by
enhanced chemiluminescence detection (ECL, Pierce) with
Image Quant LASS 4000 (GE Healthcare). Densitometry
quantification was done using Image J.
2.8. Histology. Human biopsies and rat kidneys were placed
in 4% (w/v) paraformaldehyde after explantation and were
processed for paraffin embedding. Sections (3 𝜇m) were
cut and mounted on slides. Light microscopic evaluation
was performed on sections stained by Masson trichrome to
evaluate fibrotic changes in representative renal allografts
[3].
2.9. Immunohistochemistry. The 3 𝜇m sections were sub-
jected to antigen retrieval and quenching of endogenous per-





complexes were visualized using suitable peroxidase-coupled
secondary antibodies, according to the manufacturer’s proto-
col (Histostain Plus Kit; Zymed/Invitrogen). FBPase staining
was made to discriminate the proximal tubule, and double
staining with 𝛽-catenin was performed. Additionally, to
exclude false-positive results for 𝛽-catenin nuclear transloca-
tion, we used histological slides of 𝛽-catenin from the next
section to perform single staining with Vulcan fast red. The
whole area of the biopsy samples was examined to detect cells
with nuclear localization of 𝛽-catenin.
2.10. Collagen Assay. Protein extracts from rat kidneys were
used. Total collagen content was determined using the Sircol
Collagen Assay kit (Biocolor, Belfast, Northern Ireland)
following the enhanced protocol. Samples and collagen stan-
dards were then read at 540 nm. Collagen concentrations
were calculated using a standard curve generated by using
acid-soluble type 1 collagen.
3. Results
3.1. Renal Function Analysis. All animals that undergo renal
mass reduction (RMR) showed clear loss of renal function
that it is increasing across the time. Diuresis, proteinuria,
BUN, and creatinine were highly increased in nephrec-
tomized animals as well as urinary creatinine and creatinine
clearance was markedly reduced after renal mass reduction
compared with sham animals (Table 1).
3.2. Assessment of Renal Fibrosis in RMR Model. Left kid-
ney from sham (S) and 5/6 nephrectomized (Nx) rats was
explanted at 12 or 18 weeks after surgery and underwent
qRT-PCR analysis to assess renal fibrosis. General markers
for fibroblast activation including 𝛼-smooth muscle actin
(𝛼-SMA), fibroblast-specific protein-1 (FSP1), collagen 1a1
(col1a1), and vimentin (Vim) were analyzed. In addition,
mRNA expression of the profibrotic mediators transform-
ing growth factor-𝛽 (TGF-𝛽) and plasminogen activator
inhibitor-1 (Pai1) as well as the antifibrotic bonemorphogenic
proteins 4 and 7 (BMP4 and BMP7) were analyzed.
First, we analyzed the fibroblast activation and we found
a progressive induction of FSP1 across time; Col1a1 and
Vim showed upregulation trend; however, only Vim became
statistically significant at 18 weeks (Figure 1(a)). Otherwise,
𝛼-SMA and Fn1 did not show expression regulation. The



















































































Figure 1: Assessment of fibrosis in rat 5/6 renal mass reduction model. (a) mRNA expression of general markers of fibroblast activation:
alpha smooth muscle actin (𝛼-SMA), fibroblast-specific protein-1 (FSP1), collagen 1a1 (Col1a1), vimentin (Vim), and fibronectin 1 (Fn1).
(b) Profibrogenic mediators transforming growth factor-𝛽 (TGF-𝛽), plasminogen activator inhibitor-1 (Pai1), and the antifibrotic bone
morphogenetic proteins 4 and 7 (BMP4 and BMP7), and in rat kidneys of sham animals and 5/6 mass reduction animals by quantitative
real-time PCR (qRT-PCR). Results are derived from 8-9 animals per group after 12 weeks (white columns) and 18 weeks (grey columns) after
the surgery. Columns show median of log-fold change for each gene. #𝑃 > 0.05 and ###𝑃 < 0.001, two-tailed Student’s 𝑡-test for unpaired
observations between S and Nx groups. ∗∗𝑃 > 0.01 and ∗∗∗𝑃 < 0.001, two-tailed Student’s 𝑡-test for unpaired observations between 12 and
18weeks. (c) Masson’s trichrome of representative kidneys from sham or nephrectomized (Nx) rats. Representative pictures with focus on the
cortex area are given. Green: collagen deposition. (d) Total collagen content was determined using the Sircol Collagen Assay. Columns are
showing show median of mg collagen/g kidney lysate. ###𝑃 < 0.001, two-tailed Student’s 𝑡-test for unpaired observations between S and Nx
groups.
antifibrotic gene analysis did not show significative changes
of either TGF-𝛽 or Pai1, while the antifibrotic proteins BMP4
and BMP7 were downregulated (Figure 1(b)).
Next we determined kidney fibrosis through quantifica-
tion of collagen deposition using Masson’s trichrome stain
and Sircol assay. 5/6 Nx animals showed a significant increase
of total collagen content compared with sham animals at 12
and 18 weeks after the surgery (Figure 1(c)).
3.3. Expression of the Canonical Wnt Signaling Components in
RMRModel. Wnt/𝛽-catenin activity was assessed during the
development of fibrotic remodeling in the rat 5/6 renal mass
reduction model.
AtmRNA levelWnt expression of individualWnt ligands,
receptors, intracellular signal transducers, and target genes
was assessed by qRT-PCR.Global analysis showed a tendency
to upregulation of the pathway, but only the intracellular
signal transducer 𝛽-catenin was significantly upregulated,
whereas Wnt ligands Wnt10a and Wnt5a and receptors FZD1
and FZD8 were significantly downregulated; all other Wnt
components analyzed showed tendencies (Figure 2).
To assess Wnt/𝛽-catenin signal activity, Western blot
analysis was performed to LRP6, GSK-3𝛽, 𝛽-catenin,
cyclinD1, and Wnt1 for the 18 weeks’ animal groups.
Phosphorylation of both LRP6 and GSK-3𝛽 was increased
(Figure 3), indicating activation of Wnt/𝛽-catenin signaling.
This finding correlated with increased expression of total
𝛽-catenin and of the Wnt target gene, cyclin D1, both of
which were upregulated in Nx rat samples as compared with
kidney tissue samples from sham animals. The Wnt ligand
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Figure 2: Expression of the canonical Wnt signaling components in rat 5/6 renal mass reduction model. mRNA levels of the Wnt ligands
Wnt1, Wnt3a, and Wnt10a (canonical), Wnt5a (noncanonical), and Wnt7b (Ca2+ pathway); the Wnt receptors FZD1, 2, 3, 6, and 8 and LRP5;
intracellular signal transducers 𝛽-catenin (𝛽-Cat) and glucose sintase kinase3-𝛽 (GSK-3𝛽); and the target genes axin2, lymphoid enhancer-
binding factor 1 (LEF1), TCF4, and WISP1 were assessed in rat kidneys of sham animals (S) and 5/6 mass reduction animals (Nx) by
quantitative real-time PCR (qRT-PCR). Results are derived from 8-9 animals per group after 12 weeks (white columns) and 18 weeks (grey
columns) after the surgery. Columns showmedian of log-fold change for each gene. #𝑃 > 0.05 and ###𝑃 < 0.001, two-tailed Student’s 𝑡-test for
unpaired observations between S and Nx groups. ∗∗𝑃 > 0.01 and ∗∗∗𝑃 < 0.001, two-tailed Student’s 𝑡-test for unpaired observations between
12 and 18 weeks.
Wnt1 at mRNA level showed a tendency to upregulation
(log-fold of 2.39 ± 0.87, not statistically significant), while
the Wnt1 protein level detected by Western blotting was
significantly increased (Figure 4).
To further confirm pathway activation in the animal
model, the 𝛽-catenin distribution pattern was analyzed in rat
kidney. After discrimination of proximal and distal tubules
(Figure 5(a)), 𝛽-catenin was localized to both the proximal
and distal tubules (Figures 5(b)–5(d)). Notably, positive
staining was limited to cell-cell junctions and the basal layer
in the proximal tubule (Figure 5(e)), while the distal tubule
exhibited cytoplasmic (but not nuclear) localization in sham
animals. Importantly, nuclear localization of 𝛽-catenin was
found in epithelial cells mainly on the distal tubule in Nx
animals (Figures 5(c), 5(e), and 5(f)).
4. Discussion
Renal fibrosis is one of the most common forms in chronic
kidney diseases (CKD). The goal of this study was to
characterize and validate the utility of the remnant kidney
model with 5/6 nephrectomy (5/6 Nx) for the study of the
Wnt pathway. Histological and molecular examination of
the model demonstrated the damage and the Wnt pathway
activation at 12 and 18 weeks after the surgery where we
can mimic CKD. This confirms to us that 5/6 Nx is an easy,
reliable, and good tool where Wnt pathway is activated.
Different models of renal mass reduction have been used
to study the mechanisms of the progression of CKD in
humans. In 5/6 Nx, the kidney’s adaptive response to this
surgical reduction in nephron number appears to be close
enough to the pathophysiologic characteristics of human
progressive nephropathies. 5/6 Nx is a well-described low
nephron number model of chronic progressive renal disease
with renal function impairment, proteinuria, glomerular
sclerosis, and interstitial fibrosis [15, 16]. Our group pre-
viously described histologically the model, which is char-
acterized for arteriolar hyalinosis and glomerulosclerosis.
Additionally we described glomerular hypertrophy as well
as severe tubular atrophy, interstitial fibrosis, interstitial



















































































































































Figure 3: Activity of the canonical Wnt signal pathway in kidney homogenates of sham and nephrectomized rats. The expression of active
Wnt components in kidney homogenates of sham and nephrectomized rats 18 weeks after the surgery was analyzed by immunoblotting of
LRP6, phospho-LRP6, total 𝛽-catenin, cyclin D1, GSK-3𝛽, and phospho-GSK-3𝛽. Blotting of GDPH and 𝛽-actin served as loading controls.
Results are derived from 4-5 animals per group.



























Figure 4: Expression of Wnt1 in kidney homogenates of sham
and nephrectomized rats. The expression of Wnt1 in kidney
homogenates of sham and nephrectomized rats 18 weeks after the
surgery was analyzed by immunoblotting. Blotting of GDPH served
as loading control. Results are derived from 4-5 animals per group.
inflammation, and glomerulosclerosis [16]. Fibrosis can
result from an excessive synthesis of interstitial collagens such
as collagens types I and III confirmed by trichrome stain
and Sircol analysis in the present study. General markers for
fibroblast activation, profibrotic mediators, and antifibrotic
moleculeswere analyzed.Thedifferentially regulatedmarkers
of fibrosis are summarized in Table 2. Upregulation of FSP1,
Col1a1, and Vim has been implicated in renal fibrosis and
the downregulation of the antifibrotic BMP4 and BMP7
confirmed the fibrosis establishment, while central role of
TGF-𝛽 in human and experimental models for renal fibrosis
has been well described [3, 4, 17, 18].
It is described that stimulation of canonical Wnt pathway
led to 𝛽-catenin accumulation, nuclear translocation, and
interaction with TCF/LEF complex resulting in target gene
regulation. We found upregulation at mRNA level of 𝛽-
catenin and LEF1. The Wnt/𝛽-catenin canonical pathway
plays an essential role during development, driving to
branching nephrogenesis in fetal kidney. In the adult, Wnt
signaling plays role in the control of tissue homeostasis. Wnt
pathway promotes cell proliferation, tissue expansion, cell
fate determination, and terminal differentiation.mRNAanal-
ysis of Wnt ligands showed no significant upregulation of the
canonical Wnt ligands Wnt1 and Wnt3a and downregulation
of Wnt10b. Königshoff et al. described upregulation of Wnt1
on day 7 after obstructive injury inmice followed by a decline
inmRNA levels [10]. To further confirmpathway activation at
mRNA level some target genes were analyzed, andwe showed
they are upregulated. Table 2 shows summary of regulated
genes.
When the expression distribution of 𝛽-catenin was ana-
lyzed in the rat renal tissue, 𝛽-catenin was expressed in
proximal and distal tubules, but the proximal tubules showed
basal localization and rarely citoplasmatic distribution, while
the distal tubules showed strong cytoplasmic signal. Some
nuclei of both tubules showed nuclear translocation but less
Table 2: Summary of differentially regulated genes.





BMP4 ↓n.s. ↓ ↓
BMP7 ↑n.s. ↔ ↔
Col1a1 ↑n.s. ↑n.s. ↑n.s.
FSP1 ↑n.s. ↑ ↑
Vim ↑n.s. ↑ ↔
Wnt pathway ligands
Wnt1 ↑n.s. ↑n.s. ↑n.s.
Wnt3a ↑n.s. ↑n.s. ↑n.s.
Wnt5a ↓n.s. ↓n.s. ↔
Wnt7b ↑n.s. ↑n.s. ↔
Wnt10a ↓n.s. ↓n.s. ↔
Receptors
FZD1 ↓n.s. ↓ ↓
FZD3 ↓n.s. ↓n.s. ↔
FZD6 ↔ ↓n.s. ↔
FZD8 ↓n.s. ↓ ↔
LRP5 ↓n.s. ↓n.s. ↔
Intracellular signal
transducers
𝛽-Cat ↑n.s. ↑ ↑
GSK-3𝛽 ↓n.s. ↓n.s. ↑n.s.
Target
Axin2 ↑n.s. ↔ ↔
LEF1 ↑n.s. ↑ ↔
WISP1 ↔ ↔ ↑n.s.
↑: statistically significant upregulation.
↓: statistically significant downregulation.
↑n.s.: no statistically significant upregulation.
↓n.s.: no statistically significant downregulation.
frequently than in human samples. To confirmWnt signaling
activation in fibrotic rat kidneys, the key components of
canonical Wnt signaling were analyzed at the protein level.
Our data confirm Wnt activation, as demonstrated by an
increase in the total content of 𝛽-catenin, LRP6, and GSK-
3𝛽 phosphorylation, the target gene cyclin D1, and the Wnt1
ligand, indicating that Wnt1 plays a role in IFTA progression
in the kidney, as previously described in heart and lung ani-
mal models. Duan et al. reported that Wnt1 was upregulated
eightfold in the heart within 48 h after acute ischemic cardiac
injury. These authors describe Wnt1 fibroblast proliferation
and profibrotic gene induction [19]. As in the kidney, in
the heart, there is low expression of most Wnt ligands, and
Wnt1 enhances the profibrotic function of cardiac fibroblasts,
inducing their proliferation and expression of profibrotic
genes.
In our model we observed an activation of the Wnt/𝛽-
catenin pathway but not as strong as we expected. The 5/6
Nx model with the sacrifice at 12 and 18 weeks is a really























Figure 5: Expression and localization of 𝛽-catenin of representative kidneys in Nx rats. (a) Costain against FBPase in pink (Vulcan fast
red), specific marker of proximal tubule (PT), and ATPase in brown (DAB), specific marker of distal tubule (DT), are made in serial cuts to
discriminate between tubules; in (b) and (d)𝛽-catenin stainwasmade in rat kidneys in pink (Vulcan fast red) andnuclei in blue (hematoxylin).
Higher magnifications of tubular are shown in (c) and (e); (d) showing distal tubules with the translocated nuclei (arrows); (e) showing
magnification of two proximal tubules with apical localization of 𝛽-catenin and one distal tubule with membrane localization, and short
arrows indicate 𝛽-catenin translocated nucleus. As the 𝛽-catenin stain was made with Vulcan fast red, when slices were observed with a
Texas Red filter clear image of translocated nuclei was obtained and false positives could be discarded; short arrow shows the confirmed 29
𝛽-catenin translocated nucleus (f). Representative pictures with focus on the cortex area are given. Quantification of nuclei translocated 𝛽-
catenin was done, related to proximal and distal epithelium surface. Stains are representative of using at least six different animals per group
(magnification as indicated).
advanced chronic damage. von Toerne et al. described CAD
model and they analyzed the Wnt pathway activation across
CADdevelopment but until 8 weeks after the transplantation,
and they observed upregulation across the time [2]; however
this model is useful only in the transplant context. There
are different types of CKD that mimic different types of
CKD, glomerulosclerosis models (5/6 Nx), or interstitial
fibrosis models (UUO, Cyclosporine A nephropathy, etc.).
The advantages of 5/6 Nx model include robust functional
readouts (such as proteinuria, GFR, and secondary hyper-
tension), reliable induction in rodents, and comparison to
the kidney removed at induction of injury. This model was
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useful for the elucidation of mechanisms that translate to
CKD secondary to nephron loss in humans and glomerular
disease [20]. He et al. described upregulation of the pathway
in a UUO model but to 2 weeks after the surgery [12].
For studying tubulointerstitial fibrosis, UUO is the most
widely used model. The intact nonobstructed kidney serves
as an excellent control. However, this model lacks functional
readouts in that serum creatinine is normal, there is no
proteinuria, and 15 days could not be considered as chronic
damage.
To our knowledge there are no reports about the Wnt
regulation in a long term CKD. Our results demonstrate that
pathway is active, but this is not a dramatic upregulation.That
could be attributed to the functional tissue loss, because of the
tubular and glomerular atrophy, indicating that time points
analyzed could be too late for pathway modulation. Shorter
time points will be necessary to set Wnt activation, in order
tomodulate its activation and couls study their effect onCKD
activation.
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